Effect of diabetes mellitus on 3-year outcomes in patients with acute myocardial infarction with nonobstructive arteries

被引:0
|
作者
Jaguszewski, Milosz J.
Filipiak, Krzysztof J.
Zamorano, Luis
Mario, Carlo Di
Buszman, Pawel
Kubica, Jacek
Luescher, Thomas F.
Jaguszewski, Milosz J.
机构
关键词
diabetes; MINOCA; outcomes; PERCUTANEOUS CORONARY INTERVENTION; LONG-TERM MORTALITY; VASCULAR-DISEASE; METAANALYSIS; PREVENTION;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Diabetes mellitus (DM) is a significant factor in increased mortality rates among patients with acute myocardial infarction (AMI), but research on its impact on the long-term outcomes in patients with MI with nonobstructive coronary arteries (MINOCA) is limited. Thus, a comparison of the 3-year clinical outcomes between the DM and non-DM groups among patients with MINOCA was undertaken. Methods: From the Korea AMI Registry-National Institute of Health dataset, 13,104 AMI patients were enrolled. After applying the exclusion criteria, 379 patients with MINOCA were included. The primary clinical outcomes were major adverse cardiac and cerebrovascular events (MACCE), de- fined as all-cause death, recurrent myocardial infarction (MI), repeat coronary revascularization, and stroke. The secondary outcomes were the individual components of MACCE. Results: The adjusted hazard ratios for 3-year MACCE (2.287, p = 0.010), all-cause death (2.845, p = 0.004), and non-cardiac death (non-CD, 3.914, p = 0.008) were higher in the DMgroup than in the non-DMgroup. It is speculated that the higher non-CD rate in the MINOCA group is attributable to a higher proportion of patients with non-ST-segment elevation MI in the total study population. The CD, recurrent MI, revascularization, and stroke rates were similar between the DM and non-DM groups. DM, advanced age, cardiopulmonary resuscitation on admission, and nonuse of statin medications were significant predictors of MACCE. Conclusions: In this study involving patients with MINOCA, the DMgroup exhibited a higher 3-year mortality rate than the non-DMgroup. Thus, DMdemonstrated a hazardous effect even inpatients with MINOCA. (Cardiol J 2024; 31, 5: 675-689)
引用
收藏
页数:142
相关论文
共 50 条
  • [21] Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure
    Deedwania, Prakash C.
    Ahmed, Mustafa I.
    Feller, Margaret A.
    Aban, Inmaculada B.
    Love, Thomas E.
    Pitt, Bertram
    Ahmed, Ali
    EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (05) : 551 - 559
  • [22] Diabetes mellitus adversely affects the outcomes of thrombolytic therapy in patients with acute myocardial infarction
    Tikiz, H
    Tezcan, U
    Ileri, M
    Balbay, Y
    Atak, R
    Kütük, E
    ANGIOLOGY, 2003, 54 (04) : 449 - 456
  • [23] Clinical outcomes of patients with diabetes mellitus and acute myocardial infarction treated with primary angioplasty
    Aronson, D.
    Kapeliovich, M.
    Nikolsky, E.
    Kerner, A.
    Bolous, M.
    Halabi, M.
    Hammerman, H.
    Roguin, A.
    Beyar, R.
    EUROPEAN HEART JOURNAL, 2010, 31 : 347 - 348
  • [24] Personality Traits in Patients with Myocardial Infarction with Nonobstructive Coronary Arteries
    Nero, Daniella
    Agewall, Stefan
    Daniel, Maria
    Caidahl, Kenneth
    Collste, Olov
    Ekenback, Christina
    Frick, Mats
    Henareh, Loghman
    Jernberg, Tomas
    Malmqvist, Karin
    Schenck-Gustafsson, Karin
    Spaak, Jonas
    Sorensson, Peder
    Sundin, Orjan
    Y-Hassan, Shams
    Hofman-Bang, Claes
    Tornvall, Per
    AMERICAN JOURNAL OF MEDICINE, 2019, 132 (03): : 374 - +
  • [25] Prognostic Impact of Diabetes Mellitus on Clinical Outcomes in Lean Patients With Acute Myocardial Infarction
    Hamadate, Misato
    Yokoyama, Hiroaki
    Sakai, Shuntaro
    Shikanai, Shun
    Sorimachi, Yuya
    Yamazaki, Ken
    Kitayama, Kazutaka
    Miura, Naotake
    Yokota, Takashi
    Tomita, Hirofumi
    IN VIVO, 2022, 36 (03): : 1383 - 1390
  • [26] Management of myocardial infarction with Nonobstructive Coronary Arteries (MINOCA): a subset of acute coronary syndrome patients
    Matta, Anthony G.
    Nader, Vanessa
    Roncalli, Jerome
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2021, 22 (03) : 625 - 634
  • [27] Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction - The VALsartan In Acute myocardial iNfarcTion (VALIANT) trial
    Aguilar, D
    Solomon, SD
    Kober, L
    Rouleau, JL
    Skali, H
    McMurray, JJV
    Francis, GS
    Henis, M
    O'Connor, CM
    Diaz, R
    Belenkov, YN
    Varshavsky, S
    Leimberger, JD
    Velazquez, EJ
    Califf, RM
    Pfeffer, MA
    CIRCULATION, 2004, 110 (12) : 1572 - 1578
  • [28] Withholding thrombolysis in patients with diabetes mellitus and acute myocardial infarction
    Shotliff, K
    Kaushal, R
    Dove, D
    Nussey, SS
    DIABETIC MEDICINE, 1998, 15 (12) : 1028 - 1030
  • [29] Autonomic dysfunction in patients with diabetes mellitus and acute myocardial infarction
    Jovanovic, M.
    Jakovljevic, Jovana
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 : 200 - 200
  • [30] Prevalence and Impact of Diabetes Mellitus in Patients With Acute Myocardial Infarction: A 10-year Experience
    El-Menyar, Ayman A.
    Albinali, Hajar A.
    Bener, A.
    Mohammed, Ibrahim
    Al Suwaidi, Jassim
    ANGIOLOGY, 2009, 60 (06) : 683 - 688